Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07307274
PHASE1

A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults

Sponsor: Syntis Bio

View on ClinicalTrials.gov

Summary

A Phase 1, single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacodynamics of single and multiple dose regimens of SYNT-101 in healthy and overweight adults.

Official title: A Phase 1 Randomised, Double-blind, Placebo-controlled Single Ascending and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYNT-101 in Healthy Adults and Healthy Adults Who Are Overweight or Have Obesity

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2026-01-05

Completion Date

2026-12-31

Last Updated

2026-01-15

Healthy Volunteers

Yes

Interventions

DRUG

SYNT101

Tablet

DRUG

Placebo

Placebo tablet to match SYNT101 in appearance.

Locations (1)

Veritus Research

Bayswater, Victoria, Australia